Bladder Cancer
Latest News in Bladder Cancer
October 10, 2024
Enfortumab Vedotin Plus Pembrolizumab Stands Strong as the Frontline Bladder Cancer SOC – OncLive
October 7, 2024
513 Active Bladder Cancer Clinical Trials
513 Active Bladder Cancer Clinical Trials
As of April 1, 2025
Source: clinicaltrials.gov
LOCATE
CLINICAL TRIALS